AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $37,000 | -64.1% | 616,027 | 0.0% | 0.00% | – |
| Q2 2022 | $103,000 | -93.6% | 616,027 | -82.0% | 0.00% | – |
| Q1 2022 | $1,612,000 | -16.0% | 3,430,770 | +2.0% | 0.00% | – |
| Q4 2021 | $1,918,000 | -66.3% | 3,364,395 | -1.9% | 0.00% | – |
| Q3 2021 | $5,694,000 | +21.9% | 3,429,991 | +22.6% | 0.00% | – |
| Q2 2021 | $4,671,000 | +4816.8% | 2,797,303 | +4882.9% | 0.00% | – |
| Q1 2021 | $95,000 | +6.7% | 56,138 | 0.0% | 0.00% | – |
| Q4 2020 | $89,000 | +97.8% | 56,138 | +19.9% | 0.00% | – |
| Q3 2020 | $45,000 | +50.0% | 46,838 | 0.0% | 0.00% | – |
| Q2 2020 | $30,000 | +57.9% | 46,838 | 0.0% | 0.00% | – |
| Q1 2020 | $19,000 | -29.6% | 46,838 | 0.0% | 0.00% | – |
| Q4 2019 | $27,000 | +17.4% | 46,838 | 0.0% | 0.00% | – |
| Q3 2019 | $23,000 | +27.8% | 46,838 | 0.0% | 0.00% | – |
| Q2 2019 | $18,000 | -97.0% | 46,838 | -95.7% | 0.00% | – |
| Q1 2019 | $608,000 | +51.2% | 1,082,051 | +6.2% | 0.00% | – |
| Q4 2018 | $402,000 | -26.6% | 1,018,542 | -5.6% | 0.00% | – |
| Q3 2018 | $548,000 | -70.4% | 1,078,716 | +28.2% | 0.00% | – |
| Q2 2018 | $1,851,000 | +969.9% | 841,163 | +1552.1% | 0.00% | – |
| Q1 2018 | $173,000 | +58.7% | 50,915 | +90.6% | 0.00% | – |
| Q4 2017 | $109,000 | +581.2% | 26,715 | 0.0% | 0.00% | – |
| Q3 2017 | $16,000 | +14.3% | 26,715 | 0.0% | 0.00% | – |
| Q2 2017 | $14,000 | -97.3% | 26,715 | -95.9% | 0.00% | – |
| Q1 2017 | $523,000 | -11.1% | 654,122 | +0.1% | 0.00% | – |
| Q4 2016 | $588,000 | +22.2% | 653,270 | +0.7% | 0.00% | – |
| Q3 2016 | $481,000 | -42.3% | 649,049 | +0.3% | 0.00% | – |
| Q2 2016 | $834,000 | +892.9% | 647,291 | +1639.9% | 0.00% | – |
| Q1 2016 | $84,000 | -35.9% | 37,202 | 0.0% | 0.00% | – |
| Q4 2015 | $131,000 | +23.6% | 37,202 | +1.9% | 0.00% | – |
| Q3 2015 | $106,000 | +21.8% | 36,502 | 0.0% | 0.00% | – |
| Q2 2015 | $87,000 | -97.9% | 36,502 | -93.4% | 0.00% | – |
| Q1 2015 | $4,143,000 | +141.3% | 549,984 | +9.8% | 0.00% | – |
| Q4 2014 | $1,717,000 | +5.6% | 500,992 | +8.7% | 0.00% | – |
| Q3 2014 | $1,626,000 | -57.0% | 460,742 | +1.9% | 0.00% | – |
| Q2 2014 | $3,781,000 | +34.8% | 452,279 | +2.3% | 0.00% | – |
| Q1 2014 | $2,805,000 | -30.7% | 442,059 | -39.6% | 0.00% | – |
| Q4 2013 | $4,046,000 | +66.2% | 731,760 | +125.5% | 0.00% | – |
| Q3 2013 | $2,435,000 | +33.4% | 324,470 | +2.5% | 0.00% | – |
| Q2 2013 | $1,825,000 | – | 316,534 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |